Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2019-08-07
Original market date: See footnote 1
2015-07-10
Lot number: See footnote 2
S08304
Expiry date: See footnote 2
2017-05-31
Product name:
VAN-PIOGLITAZONE
DIN:
02434148
Product Monograph/Veterinary Labelling:
Date:
2014-11-07
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
VANC PHARMACEUTICALS INC
2639 Viking Way, Unit 210
Richmond
British Columbia
Canada
V6V 3B7
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:20.28
Anatomical Therapeutic Chemical (ATC): See footnote 4
A10BG03 PIOGLITAZONE
Active ingredient group (AIG) number:See footnote5
0141541002
Active ingredient(s) | Strength |
---|---|
PIOGLITAZONE (PIOGLITAZONE HYDROCHLORIDE) | 30 MG |